Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOAH: Edoxaban in Patients With Atrial High Rate Episodes
NCT02618577Phase 3Terminated
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- Feb 2016
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of edoxaban in atrial high rate episodes (AHRE), sponsored by Kompetenznetz Vorhofflimmern. Started Feb 2016; status: terminated.
02
Drugs
edoxaban
03
Conditions
atrial high rate episodes (AHRE)
Beyond the preview
Go deeper on NCT02618577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02618577.